FDA Crushes Cellectis With Clinical Hold
Cellectis shares tumbled early on Tuesday after the firm announced that a couple of its early-stage studies were put on hold by the FDA.
All Work
Chris Lange
BioCryst Pharma Sees Brief Surge on Mid-Stage Trial Win
BioCryst Pharmaceuticals saw its shares make a handy gain on early Tuesday after it released the final results from its mid-stage clinical trial in hereditary angioedema.
Insmed More Than Doubles on Late-Stage Trial
Insmed saw its shares more than double early on Tuesday after the firm released late-stage results from its clinical study in the treatment of nontuberculous mycobacteria lung disease.
Lululemon Earnings Stretch to Another Win
Lululemon Athletica shares rose Friday in the wake of a better-than-expected fiscal second-quarter report late on Thursday.
How Palo Alto Crushed Q4 Earnings
Shares of Palo Alto Networks climbed handily after it reported better-than-expected fiscal fourth-quarter earnings results.
Even More Affected Accounts Found in Wells Fargo Scandal
Wells Fargo has announced the completion of its third-party review of retail banking accounts dating back to 2009. What reviewers found was more than what they bargained for.
FDA Crushes SteadyMed With Refusal to File Letter
SteadyMed shares plummeted after the firm had a setback from the FDA regarding its pulmonary arterial hypertension treatment.
US LBM Gears Up for IPO
Specialty building materials distributor US LBM has amended its filing with the SEC regarding its initial public offering.
Dollar General Q2 Earnings Beat Due to New Stores, Increased Traffic
Dollar General released better-than-expected fiscal second-quarter earnings report before the markets opened on Thursday.
August ADP Employment Report Beats Expectations
The ADP Employment Report was released Wednesday morning and handily topped Bloomberg expectations, which may help reset expectations for Friday's employment report from the Department of Labor.
Mazor Robotics Jumps After Medtronic Collaboration Update
Mazor Robotics saw its shares make a handy gain to kick off hump day after it was announced that the company has entered the next phase of its strategic partnership with Medtronic earlier than…
Why Otonomy Shares Are Getting Absolutely Crushed
Otonomy saw its shares crater after the firm announced results for its Averts-1 late-stage trial of Otividex in patients with Ménière’s disease.
Consumer Confidence Continues to Improve in August
Overall, consumer confidence continued to improve in August, though there were mixed readings in the latest report.
The Advisory Board Announces New Merger Agreements
The Advisory Board watched its shares make a handy gain on Tuesday after the firm announced that it had entered into a definitive merger and purchase agreement.
ImmunoGen and Jazz Enter Into Global Collaboration
ImmunoGen has decided to partner with Jazz Pharmaceuticals for the development and commercialization of two early-stage, hematology-related antibody-drug conjugate programs.
Acorda Therapeutics Shares Crushed After Receipt of FDA Refusal Letter
Acorda Therapeutics saw its shares get crushed early on Tuesday after the firm received a Refusal to File letter from the FDA in regards to its New Drug Application for Inbrija.
Gilead Moves to Acquire Kite Pharma
Gilead Sciences shares have been in a holding pattern for a while. Analysts have said that the firm needs to make a move to shake this situation, otherwise this could turn into something worse.
IXYS Surges on Incredible Deal
IXYS shares saw an incredible gain to kick off the week after it was announced that Littlefuse would be acquiring the firm. The transaction represents an equity value of approximately $750 million and enterprise…
Short Sellers Take Mixed Stance on Cybersecurity
The August 15 short interest data have been compared with the previous figures, and short interest moves in these selected cybersecurity stocks was mixed.
Social Media Short Interest Surges
The August 15 short interest data have been compared with the previous report. Short interest in most of these selected social media stocks increased for this settlement date.